Analysts’ Perspective: Mosaic (MOS), RA Pharmaceuticals (RARX), U.S. Bancorp (USB)

Investment Analysts at Citigroup upgrade The Mosaic Company (NYSE:MOS) shares from Neutral to Buy rating.

The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients worldwide.


Brokerage Firm Raymond James upgraded RA Pharmaceuticals, Inc. (NASDAQ:RARX) shares from Outperform to Strong Buy rating.

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States.


U.S. Bancorp (NYSE:USB) shares were upgraded by analysts at Macquarie from Neutral to Outperform rating.

U.S. Bancorp, a financial services holding company, provides various financial services in the United States.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at